BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 9561485)

  • 1. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
    Wagrowska-Danilewicz M; Danilewicz M
    J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell apoptosis in human lupus nephritis: a histological study.
    Faurschou M; Penkowa M; Andersen CB; Starklint H; Jacobsen S
    Lupus; 2009 Oct; 18(11):994-9. PubMed ID: 19762401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significant role of RANTES and CCR5 in progressive tubulointerstitial lesions in lupus nephropathy.
    Stasikowska O; Danilewicz M; Wagrowska-Danilewicz M
    Pol J Pathol; 2007; 58(1):35-40. PubMed ID: 17585540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
    Lu F; Shen W; Zhang X; Guo M; Lin S
    Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
    Danilewicz M; Wagrowska-Danilewicz M
    Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D; Jerse M; Vizjak A; Hvala A; Rozman B; Kos-Golja M; Bren AF
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):692-701. PubMed ID: 11020959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
    Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
    Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glomerular distribution of laminin and fibronectin in glomerulonephritis.
    Nakapoulou I; Stefanaki K; Zeis PM; Papadakis J; Boletis J; Vosnidis G; Davaris P
    Histol Histopathol; 1993 Jul; 8(3):521-6. PubMed ID: 7689370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.
    Jeruc J; Jurcić V; Vizjak A; Hvala A; Babic N; Kveder R; Praprotnik S; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):702-6. PubMed ID: 11020960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of apoptosis in human glomerulonephritis as determined by in situ non-radioactive labelling of DNA strand breaks.
    Wagrowska-Danilewicz M; Danilewicz M
    Acta Histochem; 1997 Aug; 99(3):257-66. PubMed ID: 9381909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
    Kozlovskaia NL; Kabaenkova GS; Varshavskiĭ VA; Shvetsov MIu
    Klin Med (Mosk); 1995; 73(3):93-6. PubMed ID: 8577127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
    Dai C; Liu Z; Zhou H; Li L
    Chin Med J (Engl); 2001 Aug; 114(8):864-8. PubMed ID: 11780369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
    Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
    Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.